Paperpal Prime Logo

Revista Espanola de Quimioterapia : Impact Factor & More

eISSN: 1988-9518pISSN: 0214-3429

Key Metrics

CiteScore
2.3
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.69
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Revista Espanola de Quimioterapia

Revista Espanola de Quimioterapia Journal Specifications

Overview
Publisher SOCIEDAD ESPANOLA QUIMIOTERAPIA
Language Spanish
Frequency Bi-monthly
General Details
LanguageSpanish
FrequencyBi-monthly
Publication Start Year1988
Website URLVisit website
View less

Planning to publish in Revista Espanola de Quimioterapia ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Revista Espanola de Quimioterapia

Hantavirus infection: global overview and current situation in Spain.
  • 21 Jul 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
The ICU pharmacist's contribution to antimicrobial optimization through routine pharmacist interventions.
  • 8 Jul 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Missed opportunities in HIV detection: experience in a referral hospital
  • 8 Jul 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Nasal swab-guided deescalation of empirical linezolid in respiratory infections at a secondary-level hospital: quantification of quality gaps and antimicrobial stewardship opportunities.
  • 25 Jun 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Associations between high-risk human papillomavirus genotypes: evidence of HPV16 predominance as a monoinfection and its no stronger link with high-grade lesions.
  • 16 Jun 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort.
  • 16 Jun 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Hantavirus infection: global overview and current situation in Spain.
  • 21 Jul 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
The ICU pharmacist's contribution to antimicrobial optimization through routine pharmacist interventions.
  • 8 Jul 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Missed opportunities in HIV detection: experience in a referral hospital
  • 8 Jul 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Nasal swab-guided deescalation of empirical linezolid in respiratory infections at a secondary-level hospital: quantification of quality gaps and antimicrobial stewardship opportunities.
  • 25 Jun 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Associations between high-risk human papillomavirus genotypes: evidence of HPV16 predominance as a monoinfection and its no stronger link with high-grade lesions.
  • 16 Jun 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Long-term persistence, effectiveness, safety, and metabolic impact of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination in people living with HIV in the BICTARG cohort.
  • 16 Jun 2026
  • Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

FAQs on Revista Espanola de Quimioterapia